NIRAMAI Health Analytix
NIRAMAI Health Analytix: Business Model Canvas
The nine-block Business Model Canvas, filled in only where a public source states it — empty blocks mean we haven't found a citable fact yet, not that the answer is zero.
Value Propositions
Thermalytix aims to detect breast cancer earlier without the radiation exposure of mammography, addressing late-stage detection as a key cause of breast cancer deaths.
sourceNIRAMAI cites clinical trial results showing higher accuracy and predictive value than mammography and standard thermography interpretation.
sourceAddresses a known gap where standard X-ray mammography underperforms.
sourceSMILE-100 System received US FDA clearance, allowing healthcare personnel (not just radiologists) to review and analyze thermal breast images.
sourceCustomer Segments
Deploys Thermalytix screening through tie-ups with hospital and diagnostic chains such as Apollo Clinic.
sourceGovernment health departments contract NIRAMAI for population-level screening programs, e.g. Punjab's Department of Health & Family Welfare.
sourceTargets women for whom traditional X-ray mammography is less effective, particularly those with dense breast tissue.
sourceCustomer Relationships
Channels
Reaches patients by partnering with existing hospital and diagnostic chains rather than only selling direct.
sourceDistributes screening at scale through state government health department programs, e.g. the Punjab 'Pink project'.
sourceKey Activities
Runs clinical studies to validate Thermalytix accuracy and publishes results in peer-reviewed journals and conferences.
sourceOperates population-level screening drives in partnership with state health departments.
sourceKey Resources
Core proprietary product combining a high-resolution thermal sensing device with a cloud-hosted AI/ML analytics engine.
sourceRuns nine machine learning models in production via containerized deployment.
sourceRegulatory clearance for its breast thermography device broadens the resource base for commercial deployment in the US.
sourceKey Partnerships
Runs its ML models and screening application on Google Kubernetes Engine and Firebase for scalability.
sourceThree-way partnership to deliver statewide AI-enabled breast cancer screening in Punjab.
sourceTie-up to offer contactless breast cancer screening through Apollo's clinic network.
sourceUK development finance institution provided research funding for NIRAMAI's COVID-era FeverTest screening pilot.
sourceRevenue Streams
Cost Structure
FAQs on NIRAMAI Health Analytix
What is NIRAMAI Health Analytix's business model?
NIRAMAI Health Analytix's core value proposition centers on Non-invasive, radiation-free early detection, Company-reported accuracy gains over mammography, Effective for dense breast tissue, FDA-cleared device usable by general healthcare personnel.